On Tuesday shares of Scorpio Bulkers Inc. (NYSE:SALT) closed at $2.65. UBS analyst Spiro Dounis upgraded shares of Bulkers Inc. (NYSE:SALT) to Buy from Neutral with a price target raised to $3.50 from a previous $2.75 ahead of impending vessel sales that will “lift” a “funding overhang” that has created a negative sentiment on the name since the fourth quarter 2014.
SouFun Holdings Ltd. (NYSE:SFUN) in last trading activity fell -5.09% to close at $7.65. Company weekly performance is -6.25% while its quarterly performance stands at 19.08%. SouFun Holdings Ltd. (NYSE:SFUN) is -39.90% away from its 52 week high. SouFun Holdings Limited (NYSE:SFUN) will report its unaudited first quarter 2015 financial results before the U.S. market opens on Wednesday, May 20, 2015.
On last trading day Fonar Corp. (NASDAQ:FONR) fell -0.99% to close at $11.05. Its volatility for the week is 2.50% while volatility for the month is 3.02%. FONR’s sales growth for past 5 years was 11.50% and its EPS growth for past 5 years was 48.30%. Fonar Corp. (NASDAQ:FONR) monthly performance is -11.39%. Fonar Corp. (NASDAQ:FONR) on May 11, reported fiscal third-quarter net income of $1.9 million. On a per-share basis, the Melville, New York-based company said it had profit of 31 cents.
Hyatt Hotels Corporation (NYSE:H) has 2.70% insider ownership. In last trading activity company’s stock closed at $58.55. Hyatt Hotels Corporation (NYSE:H) announced that a Hyatt affiliate has entered into an agreement with Abdulelah Mohammed Ali Maghrabi Commercial Est. for a Hyatt Place hotel and a Hyatt House hotel in Jeddah, Kingdom of Saudi Arabia (KSA). The hotels will be within one mile of each other and will be designed by Dubai-based Samuel Creations. Hyatt Place Jeddah/Medina Road and Hyatt House Jeddah/Sari Street will join the luxurious Park Hyatt Jeddah Marina, Club and Spa and the recently opened Hyatt Place Dubai/Al Rigga.
On last trading day Eli Lilly and Company (NYSE:LLY) fell -1.40% to close at $72.44. Its volatility for the week is 1.15% while volatility for the month is 1.44%. LLY’s sales growth for past 5 years was -2.10% and its EPS growth for past 5 years was -10.80%. Eli Lilly and Company (NYSE:LLY) monthly performance is -1.47%. Eli Lilly & Co. (NYSE:LLY) and BioNTech AG announced they have entered into a research collaboration to discover novel cancer immunotherapies. The companies will seek to use the power of the body’s own immune system to attack cancer cells and create possible new treatment options for cancer patients.